Mineralys Therapeutics
MLYS
MLYS
68 hedge funds and large institutions have $429M invested in Mineralys Therapeutics in 2023 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 9 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.4% more ownership
Funds ownership: 60.24% → 61.64% (+1.4%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
68
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$12.5M | |
| 2 | +$10.8M | |
| 3 | +$2.29M | |
| 4 |
DM
Deerfield Management
New York
|
+$1.84M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$1.51M |
Top Sellers
| 1 | -$8.48M | |
| 2 | -$4.7M | |
| 3 | -$3.35M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.99M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$1.8M |